Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 25.60
-0.24 (-0.93%)
Sep 11, 2026, 3:30 PM HKT
Giant Biogene Holding Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Quarter | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Revenue Revenue Growth | 2,918 | 2,406 | 3,113 | 2,998 | 2,540 | 1,918 | 1,606 | 1,380 | 984.89 | 520.6 |
Revenue Growth | -6.26% | -19.76% | 22.53% | 56.29% | 58.21% | 39.06% | 63.03% | - | 89.19% | - |
Gross Profit Gross Profit Growth | 2,318 | 1,891 | 2,542 | 2,454 | 2,093 | 1,596 | 1,351 | 1,157 | 838.25 | 447.62 |
Operating Income Operating Income Growth | 943.19 | 760.71 | 1,360 | 1,195 | 1,086 | 897.05 | 714.66 | 627.85 | 505.29 | 321.27 |
Net Income Net Income Growth | 939.71 | 732.75 | 1,182 | 1,079 | 983.16 | 784.81 | 666.94 | 384.96 | 311.04 | 289.52 |
Earnings Per Share EPS Growth | 0.89 | 0.68 | 1.13 | 1.09 | 0.97 | 0.82 | 0.66 | 0.53 | 0.41 | 0.29 |
EPS Growth | -21.24% | -37.30% | 16.50% | 33.16% | 46.97% | 53.49% | 59.31% | - | 43.10% | - |
| Fiscal Quarter | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,396 | 8,329 | 8,861 | 5,878 | 6,064 | 3,790 | 2,781 | 2,218 | - | - |
Total Debt Total Debt Growth | 12.26 | 9.69 | 6.95 | 6.71 | 1.46 | 2.73 | 2.11 | 2.59 | - | - |
Net Cash (Debt) Net Cash Growth | 7,384 | 8,319 | 8,854 | 5,872 | 6,063 | 3,787 | 2,779 | 2,216 | - | - |
Net Cash Growth | -16.61% | 41.68% | 46.05% | 55.04% | 118.16% | 70.92% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 7.00 | 7.78 | 8.44 | 5.93 | 5.99 | 3.95 | 2.76 | 2.24 | - | - |
| Fiscal Quarter | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,065 | 715.69 | 1,118 | 922.79 | 954.54 | 692.9 | 620.23 | 311.41 | 199.34 |
Capital Expenditures CapEx Growth | - | -149.25 | -278.85 | -81.35 | -165.42 | -39.34 | -186.96 | -110.06 | -42.61 | -22.72 |
Free Cash Flow Free Cash Flow Growth | - | 915.68 | 436.84 | 1,037 | 757.38 | 915.2 | 505.93 | 510.17 | 268.8 | 176.62 |
Free Cash Flow Growth | - | -11.70% | -42.32% | 13.31% | 49.70% | 79.39% | 88.22% | - | 52.19% | - |
| Fiscal Quarter | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Operating Margin | 32.33% | 31.62% | 43.70% | 39.86% | 42.76% | 46.76% | 44.51% | 45.51% | 51.30% | 61.71% |
Pretax Margin | 37.53% | 37.66% | 46.40% | 43.44% | 45.47% | 50.54% | 48.30% | 48.18% | 52.10% | 65.70% |
Profit Margin | 32.21% | 30.46% | 37.98% | 35.99% | 38.70% | 40.91% | 41.54% | 27.90% | 31.58% | 55.61% |
FCF Margin | - | 38.06% | 14.03% | 34.59% | 29.81% | 47.70% | 31.51% | 36.98% | 27.29% | 33.93% |
| Fiscal Quarter | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
PE Ratio | 14.57 | 16.64 | 24.65 | 22.95 | 24.36 | 21.73 | 29.88 | 41.68 | - | - |
Forward PE | 12.12 | 12.61 | 20.48 | 19.66 | 22.10 | 19.71 | 22.88 | 26.93 | - | - |
P/FCF Ratio | - | 23.56 | 37.82 | 26.37 | 25.75 | 22.19 | 30.94 | 37.24 | - | - |
PS Ratio | 4.58 | 5.78 | 9.12 | 8.54 | 9.66 | 8.95 | 10.53 | 12.27 | - | - |